Security · CUSIP 55414P108
MABVAX THERAPEUTICS HOLDINGS, INC.
COMMON STOCK · institutional ownership from 13F filings
13F holders
2
Shares held
217.6K
Value held
$156.0K
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q1 2016
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 197,641 | $142.0K | 0.20% |
| Geduld E E | 20,000 | $14.0K | 0.02% |
Biggest buyers
Nothing to show.
Biggest sellers
Nothing to show.